Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Primary Target Pathway Mean Normalized Growth Rate Inhibition Value Increased Fraction Dead
SUM1315MO2 Abemaciclib
0.01
CDK4/6
Cell cycle
0.7121 -0.00006
SUM1315MO2 Abemaciclib
0.031623
CDK4/6
Cell cycle
0.4510 0.01944
SUM1315MO2 Abemaciclib
0.1
CDK4/6
Cell cycle
0.3858 0.01731
SUM1315MO2 Abemaciclib
0.31623
CDK4/6
Cell cycle
0.2593 0.02543
SUM1315MO2 Abemaciclib
1.0
CDK4/6
Cell cycle
0.1952 0.02708
SUM1315MO2 Abemaciclib
3.1623
CDK4/6
Cell cycle
0.1030 0.02380
SUM1315MO2 Abemaciclib
10.0
CDK4/6
Cell cycle
-0.1445 0.14383
SUM1315MO2 Palbociclib
0.00031623
CDK4/6
Cell cycle
1.0704 -0.00082
SUM1315MO2 Palbociclib
0.001
CDK4/6
Cell cycle
0.9810 -0.00359
SUM1315MO2 Palbociclib
0.0031623
CDK4/6
Cell cycle
0.9092 -0.00352
SUM1315MO2 Palbociclib
0.01
CDK4/6
Cell cycle
0.8607 0.00206
SUM1315MO2 Palbociclib
0.031623
CDK4/6
Cell cycle
0.6245 0.01210
SUM1315MO2 Palbociclib
0.1
CDK4/6
Cell cycle
0.5170 0.02037
SUM1315MO2 Palbociclib
0.31623
CDK4/6
Cell cycle
0.3767 0.02199
SUM1315MO2 Palbociclib
1.0
CDK4/6
Cell cycle
0.4047 0.02086
SUM1315MO2 Palbociclib
3.1623
CDK4/6
Cell cycle
0.3001 0.03387
SUM1315MO2 AZD7762
0.001
CHK1/2
Cell cycle
1.1615 -0.00361
SUM1315MO2 AZD7762
0.0031623
CHK1/2
Cell cycle
1.0758 -0.00008
SUM1315MO2 AZD7762
0.01
CHK1/2
Cell cycle
1.1343 0.01760
SUM1315MO2 AZD7762
0.031623
CHK1/2
Cell cycle
0.5593 0.11440
SUM1315MO2 AZD7762
0.1
CHK1/2
Cell cycle
0.1468 0.19864
SUM1315MO2 AZD7762
0.31623
CHK1/2
Cell cycle
-0.0659 0.23559
SUM1315MO2 AZD7762
1.0
CHK1/2
Cell cycle
-0.1812 0.29971
SUM1315MO2 AZD7762
3.1623
CHK1/2
Cell cycle
-0.3637 0.33806
SUM1315MO2 AZD7762
10.0
CHK1/2
Cell cycle
-0.6526 0.66363